Cabotegravir Maintains Protective Efficacy in the Setting of Bacterial Sexually Transmitted Infections: A Secondary Analysis of HPTN 083.
Saved in:
| Title: | Cabotegravir Maintains Protective Efficacy in the Setting of Bacterial Sexually Transmitted Infections: A Secondary Analysis of HPTN 083. |
|---|---|
| Authors: | Clement ME; Department of Medicine, Louisiana State University Health Sciences Center, New Orleans, Louisiana, USA., Hanscom B; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Haines D; Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Bazan JA; Department of Internal Medicine, The Ohio State University, Columbus, Ohio, USA., Chotirosniramit N; Research Institute for Health Sciences, Chiang Mai University, Chiang Mai, Thailand., Kofron R; Department of Medicine, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California, USA., Mannheimer S; Department of Medicine, Columbia University, NewYork, New York, USA., Mayer KH; Department of Medicine, Fenway Health and Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, Massachusetts, USA., Torres Silva MS; STI/HIV Clinical Research Laboratory, Evandro Chagas National Institute of Infectious Diseases-Fiocruz, Rio de Janeiro, Brazil., Soto-Torres L; Division of AIDS, National Institute of Allergy and Infectious Diseases, Rockville, Maryland, USA., Rinehart AR; Research and Development, ViiV Healthcare, London, UK., Rooney JF; Medical Affairs, Gilead Sciences, Inc, Foster City, California, USA., Jennings A; Network and Collaborative Research Division, FHI 360, Washington D.C., USA., Gomez-Feliciano K; Network and Collaborative Research Division, FHI 360, Washington D.C., USA., McCauley M; Network and Collaborative Research Division, FHI 360, Washington D.C., USA., Grinsztejn B; STI/HIV Clinical Research Laboratory, Evandro Chagas National Institute of Infectious Diseases-Fiocruz, Rio de Janeiro, Brazil., Landovitz RJ; Department of Medicine, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California, USA. |
| Corporate Authors: | for HPTN 083 Study Team |
| Source: | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2026 Feb 25; Vol. 82 (2), pp. e387-e395. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39579334 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Cabotegravir Maintains Protective Efficacy in the Setting of Bacterial Sexually Transmitted Infections: A Secondary Analysis of HPTN 083. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Clement+ME%22">Clement ME</searchLink>; Department of Medicine, Louisiana State University Health Sciences Center, New Orleans, Louisiana, USA.<br /><searchLink fieldCode="AU" term="%22Hanscom+B%22">Hanscom B</searchLink>; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Haines+D%22">Haines D</searchLink>; Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Center, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Bazan+JA%22">Bazan JA</searchLink>; Department of Internal Medicine, The Ohio State University, Columbus, Ohio, USA.<br /><searchLink fieldCode="AU" term="%22Chotirosniramit+N%22">Chotirosniramit N</searchLink>; Research Institute for Health Sciences, Chiang Mai University, Chiang Mai, Thailand.<br /><searchLink fieldCode="AU" term="%22Kofron+R%22">Kofron R</searchLink>; Department of Medicine, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California, USA.<br /><searchLink fieldCode="AU" term="%22Mannheimer+S%22">Mannheimer S</searchLink>; Department of Medicine, Columbia University, NewYork, New York, USA.<br /><searchLink fieldCode="AU" term="%22Mayer+KH%22">Mayer KH</searchLink>; Department of Medicine, Fenway Health and Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Torres+Silva+MS%22">Torres Silva MS</searchLink>; STI/HIV Clinical Research Laboratory, Evandro Chagas National Institute of Infectious Diseases-Fiocruz, Rio de Janeiro, Brazil.<br /><searchLink fieldCode="AU" term="%22Soto-Torres+L%22">Soto-Torres L</searchLink>; Division of AIDS, National Institute of Allergy and Infectious Diseases, Rockville, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Rinehart+AR%22">Rinehart AR</searchLink>; Research and Development, ViiV Healthcare, London, UK.<br /><searchLink fieldCode="AU" term="%22Rooney+JF%22">Rooney JF</searchLink>; Medical Affairs, Gilead Sciences, Inc, Foster City, California, USA.<br /><searchLink fieldCode="AU" term="%22Jennings+A%22">Jennings A</searchLink>; Network and Collaborative Research Division, FHI 360, Washington D.C., USA.<br /><searchLink fieldCode="AU" term="%22Gomez-Feliciano+K%22">Gomez-Feliciano K</searchLink>; Network and Collaborative Research Division, FHI 360, Washington D.C., USA.<br /><searchLink fieldCode="AU" term="%22McCauley+M%22">McCauley M</searchLink>; Network and Collaborative Research Division, FHI 360, Washington D.C., USA.<br /><searchLink fieldCode="AU" term="%22Grinsztejn+B%22">Grinsztejn B</searchLink>; STI/HIV Clinical Research Laboratory, Evandro Chagas National Institute of Infectious Diseases-Fiocruz, Rio de Janeiro, Brazil.<br /><searchLink fieldCode="AU" term="%22Landovitz+RJ%22">Landovitz RJ</searchLink>; Department of Medicine, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California, USA. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22for+HPTN+083+Study+Team%22">for HPTN 083 Study Team</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229203213%22">Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</searchLink> [Clin Infect Dis] 2026 Feb 25; Vol. 82 (2), pp. e387-e395. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9203213 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1537-6591 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210584838%22">10584838 </searchLink><i>NLM ISO Abbreviation: </i>Clin Infect Dis <i>Subsets: </i>MEDLINE; In Process |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39579334 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1093/cid/ciae572 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e387 Titles: – TitleFull: Cabotegravir Maintains Protective Efficacy in the Setting of Bacterial Sexually Transmitted Infections: A Secondary Analysis of HPTN 083. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Clement ME – PersonEntity: Name: NameFull: Hanscom B – PersonEntity: Name: NameFull: Haines D – PersonEntity: Name: NameFull: Bazan JA – PersonEntity: Name: NameFull: Chotirosniramit N – PersonEntity: Name: NameFull: Kofron R – PersonEntity: Name: NameFull: Mannheimer S – PersonEntity: Name: NameFull: Mayer KH – PersonEntity: Name: NameFull: Torres Silva MS – PersonEntity: Name: NameFull: Soto-Torres L – PersonEntity: Name: NameFull: Rinehart AR – PersonEntity: Name: NameFull: Rooney JF – PersonEntity: Name: NameFull: Jennings A – PersonEntity: Name: NameFull: Gomez-Feliciano K – PersonEntity: Name: NameFull: McCauley M – PersonEntity: Name: NameFull: Grinsztejn B – PersonEntity: Name: NameFull: Landovitz RJ IsPartOfRelationships: – BibEntity: Dates: – D: 25 M: 02 Text: 2026 Feb 25 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1537-6591 Numbering: – Type: volume Value: 82 – Type: issue Value: 2 Titles: – TitleFull: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America Type: main |
| ResultId | 1 |